Life sciences
Our specialist life sciences team understand the complex nature of the sector.
Time-to-market and funding are the crucial factors driving innovation and successful new pharmaceutical product launches, which in turn, require laboratories, vivaria, pilot plants and manufacturing facilities. Avison Young’s specialists understand the pharmaceutical product life cycle as well as the technical complexities that can create significant budgetary and scheduling risk.
We’ve successfully addressed the risks that surround real estate decision making throughout all phases of the product life cycle and across all technical aspects of planning, designing, engineering and constructing any type of life science space.

Life Sciences key contacts

News and updates
-
Avison Young welcomes six new UK Principals13 June 2025
-
Land supply shortage hindering new mid-box development in West Yorkshire03 June 2025
-
Avison Young facilitates major affordable housing deal for Cityheart in Widnes03 June 2025
-
Reform is about more than planning: Leading voices unite at UKREiiF to outline definitive steps to tackle viability challenge23 May 2025